 |
|
Effects of Diet and Simvastatin on Serum Lipids, Insulin, and Antioxidants in Hypercholesterolemic Men
A Randomized Controlled Trial
Antti Jula, MD,PhD;
Jukka Marniemi, PhD;
Risto Huupponen, MD,PhD;
Arja Virtanen, MSc;
Merja Rastas, MSc;
Tapani Rönnemaa, MD,PhD
JAMA. 2002;287:598-605.
Context Limited information exists on the interaction between diet and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) and the interaction's effect on serum lipid and lipoprotein levels, insulin sensitivity, and circulating antioxidant vitamin and provitamin levels.
Objective To evaluate the separate and combined effects of diet and simvastatin therapy on serum levels of lipids, lipoproteins, antioxidants, and insulin.
Design, Setting, and Participants Randomized, controlled crossover trial conducted from August 1997 to June 1998 in 120 previously untreated hypercholesterolemic men aged 35 to 64 years who were recruited from the community in Turku, southwestern Finland.
Interventions After a 4- to 6-week placebo run-in period, participants were randomly allocated to a habitual diet (n = 60) or dietary treatment group (n = 60), and each of these groups was further randomized in a double-blind crossover fashion to receive simvastatin (20 mg/d) or placebo, each for 12 weeks (n = 30 in each group). The main goals of the dietary treatment were to reduce energy intake from saturated plus trans-unsaturated fats to no more than 10% by replacing them partly with monounsaturated and polyunsaturated fats rich in omega-3 fatty acids and to increase intake of fruits, vegetables, and dietary fiber.
Main Outcome Measures Changes in levels of total, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) cholesterol; triglycerides; apolipoprotein B; insulin; glucose; and antioxidants at week 12 of each treatment period, compared among the 4 groups.
Results Dietary treatment decreased levels of total cholesterol by 7.6% (P<.001), LDL cholesterol by 10.8% (P<.001), HDL cholesterol by 4.9% (P = .01), apolipoprotein B by 5.7% (P = .003), serum insulin by 14.0% (P = .02), and  -tocopherol by 3.5% (P = .04). Simvastatin decreased levels of total cholesterol by 20.8%, LDL cholesterol by 29.7%, triglycerides by 13.6%, apolipoprotein B by 22.4%, -tocopherol by 16.2%,  -carotene by 19.5%, and ubiquinol-10 by 22.0% (P<.001 for all) and increased levels of HDL cholesterol by 7.0% (P<.001) and serum insulin by 13.2% (P = .005). Glucose levels remained unchanged in all groups. The effects of dietary treatment and simvastatin were independent and additive.
Conclusions A modified Mediterranean-type diet rich in omega-3 fatty acids efficiently potentiated the cholesterol-lowering effect of simvastatin, counteracted the fasting insulin–elevating effect of simvastatin, and, unlike simvastatin, did not decrease serum levels of -carotene and ubiquinol-10.
Author Affiliations: Research and Development Centre of the Social Insurance Institution, Turku, Finland (Drs Jula and Marniemi and Mss Virtanen and Rastas); Department of Pharmacology and Clinical Pharmacology (Dr Huupponen), and Department of Medicine (Dr Rönnemaa), University of Turku, Finland.
RELATED ARTICLE
February 6, 2002
JAMA. 2002;287(5):655-656.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Effects of Statins on Adipose Tissue Inflammation: Their Inhibitory Effect on MyD88-Independent IRF3/IFN-{beta} Pathway in Macrophages
Abe et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:871-877.
ABSTRACT
| FULL TEXT
Simvastatin Improves Flow-Mediated Dilation but Reduces Adiponectin Levels and Insulin Sensitivity in Hypercholesterolemic Patients
Koh et al.
Diabetes Care 2008;31:776-782.
ABSTRACT
| FULL TEXT
Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E
Cangemi et al.
Eur Heart J 2008;29:54-62.
ABSTRACT
| FULL TEXT
The Role of Coenzyme Q10 in Statin-Associated Myopathy: A Systematic Review
Marcoff and Thompson
J Am Coll Cardiol 2007;49:2231-2237.
ABSTRACT
| FULL TEXT
Effects of Diet and Simvastatin on Fatty Acid Composition in Hypercholesterolemic Men: A Randomized Controlled Trial
Jula et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:1952-1959.
ABSTRACT
| FULL TEXT
Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 Diabetes
Koh et al.
Hypertension 2005;45:1088-1093.
ABSTRACT
| FULL TEXT
Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'
Chew and Watts
QJM 2004;97:537-548.
ABSTRACT
| FULL TEXT
Effect of Pravastatin on Low-Density Lipoprotein Oxidation and Myocardial Perfusion in Young Adults With Type 1 Diabetes
Janatuinen et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:1303-1308.
ABSTRACT
| FULL TEXT
Effects of Statins on Nonlipid Serum Markers Associated with Cardiovascular Disease: A Systematic Review
Balk et al.
ANN INTERN MED 2003;139:670-682.
ABSTRACT
| FULL TEXT
OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02)
Evid. Based Nurs. 2003;6:e1-1.
FULL TEXT
Effect of Atorvastatin and Fish Oil on Plasma High-Sensitivity C-Reactive Protein Concentrations in Individuals with Visceral Obesity
Chan et al.
Clin. Chem. 2002;48:877-883.
ABSTRACT
| FULL TEXT
Mediterranean Diet Augments Benefits of Statins and Reduces Insulin Levels
Journal Watch Cardiology 2002;2002:1-1.
FULL TEXT
|
